Srividya Neelakantan

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

Johnny Mahlangu, Jerry S. Powell, Margaret V. Ragni et al. · Blood · 2013 · 441 citations · Full text

Medicine, Hematology, Molecular Biology +14

Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A

Guy Young, Johnny Mahlangu, Roshni Kulkarni et al. · Journal of Thrombosis and Haemostasis · 2015 · 169 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study

Silvio Danese, Maria Kłopocka, Ellen Scherl et al. · Clinical Gastroenterology and Hepatology · 2021 · 91 citations · Full text

Life Sciences, Immunology, Autoimmunity +12

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

Amy D. Shapiro, Margaret V. Ragni, Roshni Kulkarni et al. · Journal of Thrombosis and Haemostasis · 2014 · 64 citations · Full text

Medicine, Hematology, Hemostasis +10

Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis

Mina Hassan‐Zahraee, Zhan Ye, Xi Li et al. · Inflammatory Bowel Diseases · 2021 · 51 citations · Full text

Life Sciences, Immunology, Pathobiology +17